In a mouse model, the authors compare HNF1B and ECI2 protein expression at different stages of prostate cancer development and concluded that during tumor progression, the protective effect of HNF1B is lost, and that is associated with an increased expression of ECI231. This evidence concerns the gene HNF1B and neoplasm.